Quantcast

CME Outfitters Announces New neuroscienceCME Live and On Demand Broadcast: ‘Measuring Lipids in Patients with Bipolar Disorder: Why We Must’

November 18, 2010

Offered as a simultaneous satellite broadcast, webcast, and telephone audioconference premiering Wednesday, December 1, 2010, from 12:00 p.m.-1:00 p.m. ET, the continuing education activity seeks to increase clinician knowledge of and performance against the STABLE measure related to assessment of hyperlipidemia in patients with bipolar disorder who are being treated with an atypical antipsychotic agent.

Rockville, MD (PRWEB) November 16, 2010

CME Outfitters, LLC, (CMEO) an award-winning accredited provider of multidisciplinary continuing education (CE), in co-sponsorship with USF Health, is pleased to announce an upcoming interactive, evidence-based neuroscienceCME Live and On Demand continuing education activity titled “Measuring Lipids in Patients with Bipolar Disorder: Why We Must.”

Offered as a simultaneous satellite broadcast, webcast, and telephone audioconference premiering Wednesday, December 1, 2010, from 12:00 p.m.-1:00 p.m. ET, the activity seeks to increase clinician knowledge of and performance against the STABLE measure related to assessment of hyperlipidemia in patients with bipolar disorder who are being treated with an atypical antipsychotic agent. This activity also includes a special “After the Show” segment from 1:00 p.m.-1:30 p.m. ET during which the faculty answers additional audience questions in an informal Q&A session. The recorded webcast will re-air from 4:00 p.m.-5:00 p.m. ET. This CE activity will also be available on demand as a webcast, podcast, and telephone audioconference shortly after the broadcast premiere.

There is no fee to participate or receive CE credit for this activity; however, registration is required. Three forms of registration are accepted:
Online: Visit the activity details page at http://www.neuroscienceCME.com/PR518 and click the Register for Live Webcast icon.
Phone: Call 877.CME.PROS (877.263.7767).
Fax: Visit the activity details page at http://www.neuroscienceCME.com/PR518, print and complete the activity details form, and fax to 614.929.3600.

Statement of Need:
The STandards for BipoLar Excellence (STABLE) project outlined 15 evidence-based measures for quality assessment and improvement of care for patients with bipolar disorder (BPD). One of these relates to lipid measurement and assesses “the percentage of patients diagnosed with bipolar disorder and treated with an atypical antipsychotic agent who receive at least one assessment for hyperlipidemia within the initial 16 weeks of treatment.” This STABLE measure is based on joint recommendations from the American Psychiatric Association (APA) and the America Diabetes Association (ADA) and the fact that studies quantifying levels of clinician performance reveal that this assessment is underperformed.

This educational intervention is designed to help you improve your practice by addressing clinician gaps in and health system barriers to implementation of consistent lipid measurement. Thus, neuroscienceCME Live and On Demand activity will provide the rationale for lipid measurement in bipolar disorder pharmacotherapy and strategies for increasing the frequency with which you perform it and respond appropriately to test results.

Faculty:
Paul E. Keck, Jr., MD (Moderator)
President-CEO, Lindner Center of HOPE
Professor of Psychiatry & Behavior Neuroscience
University of Cincinnati College of Medicine
Cincinnati, OH

David C. Henderson, MD
Associate Professor of Psychiatry
Harvard Medical School
Director, Schizophrenia, Diabetes, and Weight Reduction Research Program
Director, The Chester M. Pierce, MD, Division of Global Psychiatry
Massachusetts General Hospital
Boston, MA

Roger S. McIntyre, MD, FRCPC
Associate Professor of Psychiatry and Pharmacology
University of Toronto
Head, Mood Disorders Psychopharmacology Unit
University Health Network
Toronto, ON

Learning Objectives:
At the end of this CE activity, participants should be able to:

  • Identify strategies to overcome barriers that hinder lipid measurement.
  • Increase the rate at which you perform at least one assessment for hyperlipidemia within the initial 16-week treatment period among patients with BPD who are being treated with an atypical antipsychotic agent, in accordance with the STABLE measure regarding lipid assessment.
  • Select an appropriate clinical strategy for addressing an abnormal lipid test.

Target Audience:
Physicians, physician assistants, nurses, nurse practitioners, psychologists, pharmacists, social workers, certified case managers, and other healthcare professionals with an interest in bipolar disorder.

Financial Support:
This activity is supported by an educational grant from Janssen, a Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC., and from Lilly USA, LLC. For further information concerning Lilly grant funding, visit http://www.lillygrantoffice.com.

Credit Information:
This activity offers CE credit for:

  • Physicians (CME)
  • Nurses (CNE)
  • Pharmacists (ACPE)
  • Psychologists (APA)
  • Social Workers (NASW)
  • Certified Case Managers (CCMC)

All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.
Credit Expiration Date: Thursday, December 1, 2011

Post-tests, credit request forms, and activity evaluations must be completed online at http://www.neuroscienceCME.com/test (requires free account activation), and participants can print their certificate or statement of credit immediately (70% pass rate required).

Faculty Disclosure:
USF Health adheres to the ACCME Standards regarding commercial support of continuing medical education. It is the policy of USF Health that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved, and also that speakers will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation. Detailed disclosure is presented to the learner prior to registration at http://www.neuroscienceCME.com/PR518.

About CME Outfitters:
CME Outfitters develops and distributes live, recorded, print, and web-based educational activities to thousands of clinicians each year and offers expert accreditation services for non-accredited organizations. For a complete catalog of certified activities, please visit http://www.cmeoutfitters.com, http://www.neuroscienceCME.com, or call 877.CME.PROS (877.263.7767).

About neuroscienceCME:
neuroscienceCME.com is the award-winning web portal serving clinicians, educators, and researchers in the neurosciences. Launched in October 2006, neuroscienceCME.com was custom designed to fill an identified gap in online resources for professionals around the world who are practicing in areas related to psychiatry, sleep disorders, addiction and substance abuse, ADHD, and other areas related to brain function. The site’s primary mission is to be the professional’s central forum for accessing, debating, synthesizing, and implementing the latest findings and best practices in the neurosciences. Clinical Compassâ“¢, a bi-weekly e-newsletter published by CME Outfitters, is a convenient way to stay informed of all neuroscienceCME news and information. To subscribe, visit http://www.neuroscienceCME.com and click on “Subscribe to Clinical Compassâ“¢.”

About USF Health (University of South Florida):
USF Health produces educational activities that are scientifically valid, free of commercial bias, and based on the principles of adult learning. These activities are developed around specific needs related to gaps in competence, performance, and/or patient outcomes, and, whenever possible, offer education delivered in settings best suited to the intended results.

Contact: Rachel Ellis
CME Outfitters, LLC
614.328.4506 direct
614.929.3600 fax

###

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2010/11/prweb4722054.htm


Source: prweb



comments powered by Disqus